HKUMed Researchers Mapped SARS-CoV-2 Variant Replication
New study details how specific Omicron sublineages shift their replication preference between respiratory and intestinal tissues.
Updated on Oct. 6, 2026 in Life Sciences
Live Poll
Do you trust current medical research to accurately track how new virus variants spread?
Researchers at HKUMed have identified distinct biological mechanisms that allow specific SARS-CoV-2 Omicron sublineages to target respiratory versus intestinal tissues. The study, published in Nature Communications, highlights how variants like BA.2.86 and JN.1 favor gut infection over respiratory pathways.
Why it matters
Understanding how viral evolution alters tissue tropism helps scientists determine whether shifts in disease transmission and severity are driven by intrinsic viral properties rather than existing population immunity. This research provides a framework for tracking emerging strains that may utilize alternate transmission routes, such as fecal contamination.
The study utilized organoids—miniature, three-dimensional tissue models grown from stem cells—to compare Omicron variants ranging from BA.1 to JN.1. Researchers observed that while XBB.1.5 and EG.5.1 replicate efficiently in bronchial tissues, JN.1 triggers lower inflammation levels within gut tissues compared to other sites.
The players
HKUMed
The Faculty of Medicine at the University of Hong Kong, which conducts extensive research on viral pathogenesis and public health.
The details
Experiments used human bronchial tissues, lung tissue, airway organoids, proximal intestinal enteroids (small-scale models of the intestinal lining), and colon cells to isolate viral behavior. By maintaining identical laboratory conditions, researchers identified that EG.5.1 utilizes two distinct pathways to enter human cells. These findings suggest the virus is diversifying its cellular entry mechanisms to expand its host tissue range.
Timeline
October 6, 2026: Research findings were published in the journal Nature Communications.
The Tech Race
This work follows a pattern set by previous comparative studies aiming to distinguish viral evolution from waning immunity. It marks a shift toward mapping the structural biological properties of newer Omicron sublineages, such as JN.1, against established benchmarks like BA.1.
The findings primarily assist public health officials in planning surveillance for potential fecal-oral transmission risks associated with specific variants like JN.1. There is no immediate change for the general public, as the data describes fundamental viral behavior within controlled organoid environments.
The takeaway
The research confirms that SARS-CoV-2 variants are actively evolving toward different tissue-specific infection strategies. Future developments to watch include updated clinical surveillance data confirming if the intestinal replication observed in organoids matches transmission patterns in human patients.
Further reading
For more research on how pathogens evolve, visit the Life Sciences section.
Source note: This article includes information reported by The HKU Lead.
Live Poll
Do you trust current medical research to accurately track how new virus variants spread?
